Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors

Persistent infection with high-risk human papillomaviruses (hrHPV) types is causally linked with the development of cervical precancer and cancer. HPV types 16 and 18 cause approximately 70% of cervical cancers worldwide. To evaluate the harms and protection of prophylactic human papillomaviruses (H...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Cochrane database of systematic reviews Ročník 5; s. CD009069
Hlavní autoři:	Arbyn, Marc, Xu, Lan, Simoens, Cindy, Martin-Hirsch, Pierre Pl
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England 09.05.2018
Témata:	Adolescent Adult Female Human papillomavirus 16 Human papillomavirus 18 Humans Middle Aged Papillomavirus Infections - complications Papillomavirus Infections - mortality Papillomavirus Infections - prevention & control Papillomavirus Vaccines - administration & dosage Papillomavirus Vaccines - adverse effects Precancerous Conditions - mortality Precancerous Conditions - prevention & control Precancerous Conditions - virology Pregnancy Pregnancy Outcome Randomized Controlled Trials as Topic Uterine Cervical Dysplasia - mortality Uterine Cervical Dysplasia - prevention & control Uterine Cervical Dysplasia - virology Uterine Cervical Neoplasms - mortality Uterine Cervical Neoplasms - prevention & control Uterine Cervical Neoplasms - virology Vaccination Young Adult
ISSN:	1469-493X, 1469-493X
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!